Priority Date: 19.06.06 (US 20060805171P)

Modified factor VIII and factor IX genes and vectors for gene therapy

  • Application ID: EP14190181
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 1995
1179.38
Headquarter in Leeds and 13 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 172 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 19.06.2006 - Priority Date (US 20060805171P)
  • 18.03.2015 - Publication A1 (EP2848253)

IPC Classification